The "Concept" of Parametria in the Treatment of Deep Infiltrating Endometriosis

Sponsor
Catholic University of the Sacred Heart (Other)
Overall Status
Recruiting
CT.gov ID
NCT04671004
Collaborator
(none)
100
1
12
8.4

Study Details

Study Description

Brief Summary

Background Deep infiltrating endometriosis (DIE) is most commonly located at the uterosacral ligaments, rectovaginal septum, pararectal space and vesicouterine fold. A nodule within the uterosacral ligaments (i.e involvement of the dorsal parametrium), increases the complexity of surgical resection. Parametrial involvement in DIE cases occurs in 25% of patients with severe endometriosis, possibly with hypogastric/sacral plexus or sciatic nerve involvement. The bladder functional impairment, after surgery for DIE involved the parametria, may vary between the 6.5% to 32.8%. Preservation of the hypogastric and pelvic splanchnic nerves represents the key aspect in pelvic surgery to prevent postoperative voiding disfunction. Several techniques for the excision of DIE have been described, but large, prospective RCTs are lacking. In particular, a clear standardization of the parametrectomy for DIE is missing. Systematic reviews on the surgical treatment of DIE demonstrated that it is impossible to compare the literature about the parametrectomy for DIE, because to unclear definitions and lack of standardization. We therefore believe it is necessary to propose a standardization of the definition of parametrectomy performed during procedures for DIE, to allow a clear comparison in the future between scientific works on surgical treatment of DIE, as already widely accepted in gynaecologic oncology with the classification of radical hysterectomy of Querleu-Morrow. In particular we believe that the parametrectomy for DIE must be described based on its anatomical extension and focused on the concepts of nerve sparing dissection, and vascular structures preservation, to reduce the risk of complications due to ischemia (i.e. ureter fistula).

Rationale A standardized description of the procedure (parametrectomy) will allow the comparison between the different techniques in terms of functionality preservation of the pelvic sympathetic and parasympathetic neural pathway. Therefore, the availability of a clear classification able to define parametria involvement during surgery would be clinically relevant, as they would allow to optimize counselling (risk of neurological consequences) and surgery planning.

Type of the study Multicentric prospective observational study. Primary objective To determinate the incidence of bladder functional impairment, after surgery for DIE involved the parametria.

Secondary objectives To classify the parametrectomy into a clear system of classification, based on anatomical landmark, and evaluate intra/postoperative complication to each classes of proposed parametrectomy.

Sample size The sample size has been calculated on the basis of the primary objective; in order to detect a proportion of bladder functional impairment of 30%, with a confidence level of 95% and a margin of error of 9%, a sample of N=100 patients is required.

Inclusion criteria - Patient scheduled for surgery for DIE

  • Confirmation of DIE needed of parametrectomy at laparoscopic surgery Exclusion criteria

  • Patients younger than 18 years and older than 50 years at time of operation

  • Refusal to answer the questionnaires

  • Absence of sexual activity

  • Diagnosis of multiple sclerosis

  • Pre-operative urodynamic diagnosis of neurogenic bladder dysfunction Statistical analysis The sample will be described in its clinical and demographic characteristics using descriptive statistics techniques. Qualitative variables will be summarized as frequencies and percentages. Quantitative variables will be presented as mean (std.dev). Normality of data will be checked with Kolmogorov-Smirnov test. The primary objective will be achieved calculating the incidence of bladder functional impairment after surgery. The secondary objective will be achieved using descriptive statistics techniques already described.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The "Concept" of Parametria: a Proposed Classification of Parametrectomy for the Treatment of Deep Infiltrating Endometriosis. A Prospective, Clinical Trial
    Actual Study Start Date :
    Jun 1, 2020
    Anticipated Primary Completion Date :
    Mar 31, 2021
    Anticipated Study Completion Date :
    May 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Bladder functional impairment [six months]

      To determinate the incidence of bladder functional impairment, after surgery for DIE involved the parametria

    Secondary Outcome Measures

    1. parametrectomy classification [six months]

      To classify the parametrectomy into a clear system of classification, based on anatomical landmark, and evaluate intra/postoperative complication to each classes of proposed parametrectomy

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patient scheduled for surgery for DIE

    • Confirmation of DIE needed of parametrectomy at laparoscopic surgery

    Exclusion Criteria:
    • Patients younger than 18 years and older than 50 years at time of operation

    • Refusal to answer the questionnaires

    • Absence of sexual activity

    • Diagnosis of multiple sclerosis

    • Pre-operative urodynamic diagnosis of neurogenic bladder dysfunction

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Catholic University of Sacred Heart Rome, Rome, Rome Italy 00100

    Sponsors and Collaborators

    • Catholic University of the Sacred Heart

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Prof. Giovanni Scambia, Professor, Catholic University of the Sacred Heart
    ClinicalTrials.gov Identifier:
    NCT04671004
    Other Study ID Numbers:
    • ID 3408
    First Posted:
    Dec 17, 2020
    Last Update Posted:
    Dec 17, 2020
    Last Verified:
    Dec 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 17, 2020